Lisa Smits
0000-0002-4090-0738
3 papers found
Refreshing results…
Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel Disease
Colorectal Cancer Risk in Patients With Lynch Syndrome and Inflammatory Bowel Disease
Elective switching from Remicade (R) to biosimilar CT-P13 in inflammatory bowel disease patients: a prospective observational cohort study
Missing publications? Search for publications with a matching author name.